Literature DB >> 27173746

Adherence to long-term anticoagulation treatment, what is known and what the future might hold.

John K Abdou1,2, Vivian Auyeung1, Jignesh P Patel1,2, Roopen Arya2.   

Abstract

Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non-adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non-adherence to long-term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM-B (capability, opportunity, motivation and behaviour) psychological model of non-adherence, we present the available evidence, not only in terms of describing the extent of the non-adherence problem, but also describing why patients do not adhere, offering theory-driven and evidence-based solutions to improve long-term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  atrial fibrillation; direct oral anticoagulants; medication adherence; venous thromboembolism; vitamin K antagonists

Mesh:

Substances:

Year:  2016        PMID: 27173746     DOI: 10.1111/bjh.14134

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

1.  Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial.

Authors:  Michelle R Castelli; Catherine A Saint; Brandon T Nuziale; Gretchen M Stern; Zachary A Stacy; Andrew J Crannage; Jamie M Pitlick
Journal:  Hosp Pharm       Date:  2017-07-25

Review 2.  Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel.

Authors:  Wubshet H Tesfaye; Daniel Erku; Alemayehu Mekonnen; Yonas Getaye Tefera; Ronald Castelino; Kamal Sud; Jackson Thomas; Kehinde Obamiro
Journal:  J Nephrol       Date:  2021-02-09       Impact factor: 3.902

Review 3.  Individual risk factors predictive of major trauma in pre-hospital injured older patients: a systematic review.

Authors:  Abdullah Pandor; Gordon Fuller; Munira Essat; Lisa Sabir; Chris Holt; Helen Buckley Woods; Hridesh Chatha
Journal:  Br Paramed J       Date:  2022-03-01

4.  Warfarin Use and Mortality, Stroke, and Bleeding Outcomes in a Cohort of Elderly Patients with non-Valvular Atrial Fibrillation.

Authors:  Bradshaw Pamela J; Hung Joseph; Knuiman Matthew; Briffa Thomas G; Nedkoff Lee; Katzenellebogen Judith M; Rankin Jamie M; Sanfilippo Frank M
Journal:  J Atr Fibrillation       Date:  2019-06-30

5.  Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

Authors:  Myrthe M A Toorop; Qingui Chen; Marieke J H A Kruip; Felix J M van der Meer; Melchior C Nierman; Laura Faber; Lies Goede; Suzanne C Cannegieter; Willem M Lijfering
Journal:  J Thromb Haemost       Date:  2021-11-23       Impact factor: 16.036

6.  A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.

Authors:  V Speed; R K Patel; R Byrne; L N Roberts; R Arya
Journal:  Thromb Res       Date:  2020-05-16       Impact factor: 3.944

7.  Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.

Authors:  Gudula J A M Boon; Nienke van Rein; Harm Jan Bogaard; Yvonne M Ende-Verhaar; Menno V Huisman; Lucia J M Kroft; Felix J M van der Meer; Lilian J Meijboom; Petr Symersky; Anton Vonk Noordegraaf; Frederikus A Klok
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

8.  Patients' Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis.

Authors:  Marieke G M Weernink; Melissa C W Vaanholt; Catharina G M Groothuis-Oudshoorn; Clemens von Birgelen; Maarten J IJzerman; Janine A van Til
Journal:  Am J Cardiovasc Drugs       Date:  2018-12       Impact factor: 3.571

9.  Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range.

Authors:  Leiliane Marcatto; Bruno Boer; Luciana Sacilotto; Natália Olivetti; Francisco Carlos Costa Darrieux; Maurício Ibrahim Scanavacca; Alexandre Costa Pereira; Paulo Caleb Junior Lima Santos
Journal:  J Thromb Thrombolysis       Date:  2020-09-24       Impact factor: 2.300

10.  Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: Insights from the Switching Study.

Authors:  John K Bartoli-Abdou; Jignesh P Patel; Rosa Xie; Olubanke Dzahini; Bipin Vadher; Alison Brown; Lara N Roberts; Raj K Patel; Roopen Arya; Vivian Auyeung
Journal:  Res Pract Thromb Haemost       Date:  2018-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.